Amerigo Scientific Launches High-Quality iPSC-Derived Cells to Advance Biomedical Research and Cell Therapy

Amerigo Scientific recently announced the release of high-purity, premium-quality induced pluripotent stem cell (iPSC)-derived cells and engineered reporter iPSC-derived cells, aiming to provide robust research tools for disease mechanism exploration, high-throughput drug screening, and innovative cell therapy development. The company states that these products address practical and ethical challenges associated with embryonic stem cells by using reprogrammed somatic cells, which can be derived from various adult tissues such as adipose stem cells, amniotic cells, dental pulp cells, and skin fibroblasts.

iPSC-derived cells offer high consistency with in vivo cells and primary cells in transcription, cellular structure, and biological functions, while maintaining stable genetic information. Compared to primary tissue-derived cells, they are easier to acquire, culture, and maintain. Notably, they are highly amenable to genome editing technologies like CRISPR-Cas9 and TALENs, enabling flexible genetic modifications for customized research. Patient-specific iPSCs and their differentiated derivatives retain disease-related phenotypic characteristics, making them ideal models for studying inherited and acquired human diseases. Human iPSCs carrying disease-causing genotypes also show potential for accelerating novel cell therapy research and industrialization.

Amerigo Scientific's product catalog includes more than 10 types of iPSC-derived cell products and supporting reagents, covering multiple cell types for neuroscience, vascular research, and disease modeling. The range features BrainFast Neuronal Maturation Supplement, human iPSC-derived spinal motor neurons, spinal astrocytes, mixed cortical neurons, midbrain dopaminergic neurons, microglia, medium spiny GABAergic neurons, and endothelial cells. All products are offered in standardized specifications with clear cell sources and pricing, ensuring a reliable and traceable supply for laboratories worldwide.

With these offerings, Amerigo Scientific aims to facilitate deeper exploration of disease pathogenesis, accelerate new drug discovery and toxicity assessment, and drive continuous progress in global cell therapy research. The company remains committed to providing high-standard biological research materials and supporting the development of cutting-edge life science and translational medicine.